StockNews.com Begins Coverage on Retractable Technologies (NYSE:RVP)

Equities researchers at StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a research report issued on Thursday. The brokerage set a “hold” rating on the stock.

Retractable Technologies Stock Performance

Shares of Retractable Technologies stock opened at $0.70 on Thursday. The firm has a market cap of $21.00 million, a PE ratio of -1.30 and a beta of 2.08. The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01. Retractable Technologies has a 52 week low of $0.56 and a 52 week high of $1.22. The business’s fifty day simple moving average is $0.78 and its 200-day simple moving average is $0.74.

Institutional Investors Weigh In On Retractable Technologies

An institutional investor recently raised its position in Retractable Technologies stock. Renaissance Technologies LLC increased its stake in shares of Retractable Technologies, Inc. (NYSE:RVP) by 9.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 361,253 shares of the company’s stock after purchasing an additional 31,140 shares during the period. Renaissance Technologies LLC owned approximately 1.21% of Retractable Technologies worth $249,000 at the end of the most recent reporting period. 7.58% of the stock is currently owned by hedge funds and other institutional investors.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.